Met-MDS Injection
Marketer
Metta Life Sciences Private Limited
Salt Composition
Azacitidine (100mg)
Overview Met-MDS Injection
Myelodysplastic syndrome (MDS), a type of blood cancer affecting adults, is treated with Met-MDS Injection. This injection addresses all MDS subtypes and may be prescribed for other conditions under a physician's discretion. Administered intravenously under medical supervision, the dosage and frequency are determined by your doctor based on your individual needs and may vary. Strict adherence to your physician's instructions is crucial; improper usage can lead to severe adverse reactions. Therapeutic benefits might not be immediately apparent, potentially taking weeks or months; discontinue use only as directed by your doctor. Common side effects include injection site inflammation (pain, swelling, redness), nausea, vomiting, and fatigue. Report any concerning side effects to your physician; management strategies may be available. Vaccination during treatment requires prior consultation with your doctor. Regular blood tests monitoring blood cell counts, along with liver, kidney, and heart function, are necessary. Inform your doctor of any existing liver or kidney issues, infections, or concurrent medications (including those for infections), as drug interactions are possible. Met-MDS Injection is contraindicated during pregnancy and breastfeeding.
Uses of Met-MDS Injection
Myelodysplastic syndromes: Blood cancer therapies
Major Benefits of Met-MDS Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
Common Side effects of Met-MDS Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Met-MDS Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Met-MDS Injection works:
Met-MDS Injection is an anti-neoplastic agent. Its mechanism of action involves disrupting the genetic replication of leukemic cells, targeting both DNA and RNA. This cytotoxic effect eliminates cancerous cells, facilitating the healthy development and maturation of myeloid cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Met-MDS Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Met-MDS Injection during pregnancy is contraindicated due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Met-MDS Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administering Met-MDS Injection might induce adverse reactions that could impair driving capabilities. Fatigue is one such potential side effect of Met-MDS Injection, potentially impacting driving ability.
KidneyCAUTION
Exercise caution when administering Met-MDS Injection to individuals with impaired renal function. Dosage modification of Met-MDS Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should receive Met-MDS Injection with careful monitoring. Dosage modification of Met-MDS Injection may be necessary. Physician consultation is advised. Met-MDS Injection is contraindicated in patients exhibiting advanced hepatocellular carcinoma.
What if you forget to take Met-MDS Injection :
NA
Facts to Know About Met-MDS Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Category | Metabolic Inhibitors |
3,018 People bought this recently